Epitome Biosystems Developing Phosphoarray; Tool Will Compete With Invitrogen s New Chips | GenomeWeb

A year and a half after it was founded, Epitome Biosystems has received a $500,000 Phase II Small Business Innovation Research grant from the National Science Foundation to develop an array of protein kinases with known phosphorylation sites, the company said this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.